Yadanzigan
CAS No. 76588-87-9
Yadanzigan ( Yadanzigan )
产品货号. M39223 CAS No. 76588-87-9
Yadanzigan (YDZG) is an anti-inflammatory agent and a NLRP3 inhibitor. Yadanzigan specifically inhibits NLRP3 activation via inhibiting NF-κB pathway and Reactive Oxygen Species production. Yadanzigan also moderates LPS -induced acute lung injury (ALI) in mice.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥4860 | 有现货 |
|
| 25MG | 获取报价 | 有现货 |
|
| 50MG | 获取报价 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Yadanzigan
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Yadanzigan (YDZG) is an anti-inflammatory agent and a NLRP3 inhibitor. Yadanzigan specifically inhibits NLRP3 activation via inhibiting NF-κB pathway and Reactive Oxygen Species production. Yadanzigan also moderates LPS -induced acute lung injury (ALI) in mice.
-
产品描述Yadanzigan (YDZG) is an anti-inflammatory agent and a NLRP3 inhibitor. Yadanzigan specifically inhibits NLRP3 activation via inhibiting NF-κB pathway and Reactive Oxygen Species production. Yadanzigan also moderates LPS -induced acute lung injury (ALI) in mice.
-
体外实验Yadanzigan (5 mg/kg, 10 mg/kg; 静脉注射; 共 3 次) 预防 LPS 诱导的小鼠急性肺损伤。Animal Model:Male BABL/C mice (18-22 g) Dosage:5 mg/kg, 10 mg/kg Administration:Intravenous injection; dose at 2 h prior to and 6 h, 12 h after LPS induction Result:Reduced LPS-induced infiltration of inflammatory cells and cytokine levels, such as TNF-α and IL-6. Inhibited NLRP3 inflammasome activation in lung tissue.Resulted significantly greater survival rate.
-
体内实验Yadanzigan (20, 40, 80 μM; 1 h) 促进 RAW264.7 巨噬细胞的 Nrf2 从细胞质转位到细胞核。Yadanzigan (20 μM; 1 h) 抑制 LPS 诱导 HEK293T 细胞线粒体活性氧 (ROS) 的生成 (1 μg/mL; 6 h)。Yadanzigan (40 μM; 1 h) 显著阻断 J774A 细胞在LPS和ATP诱导下 NLRP3 炎性小体的形成。Yadanzigan (2.5-10 μM 或 10-40 μM; 1, 6, 12 h) 增强J774A.1 和 THP-1 细胞中 TRIM31 表达,促进 NLRP3 蛋白降解。Western Blot AnalysisCell Line:J774A.1, and THP-1 cells Concentration:For J774A.1: 2.5 μM, 5 μM, and 10 μM; For THP-1: 10 μM, 20 μM, and 40 μM Incubation Time:For J774A.1: 6 h, 12 h; For THP-1: 1 hour; 2 h before 1 μg/mL LPS stimulated and another 30 min before 5 mM ATP induced Result:Led to a sharp decrease in NLRP3 expression in J774A.1 cells.Led to a large decrease in NLRP3 protein expression in a dose-dependent manner in THP-1 cells.Immunofluorescence Cell Line:RAW264.7 macrophages, THP-1 cells Concentration:20, 40, and 80 μM Incubation Time:Pre-treated for 1 h, continue to incubate for 18 h Result:Decreased caspase-1 p20 activation and mature IL-1β and inhibited cleaved caspase-1 release into supernatants.
-
同义词Yadanzigan
-
通路Others
-
靶点Other Targets
-
受体NLRP3 inflammasome
-
研究领域———
-
适应症———
化学信息
-
CAS Number76588-87-9
-
分子量574.6
-
分子式C26H38O14
-
纯度>98% (HPLC)
-
溶解度———
-
SMILES———
-
化学全称———
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Cui Y, et al. Yadanzigan, a quassinoid glucoside, attenuates NLRP3 inflammasome activation to prevent LPS-induced acute lung injury. Authorea Preprints, 2020.
产品手册
关联产品
-
Mudanpioside C
牡丹皮苷 C 是芍药中的天然产物。
-
6,7-Dihydroxy-2,4-di...
5,7-Dimethoxy-2,3-phenanthrenediol 具有雌激素活性。5,7-Dimethoxy-2,3-phenanthrenediol 可促进 MCF-7 细胞增殖及 ERβ 在 MCF-7 细胞系中的表达。
-
1-(1-phenyltetrazol-...
1-(1-苯基四唑-5-基)哌嗪;盐酸盐 是一种化合物。
021-51111890
购物车()
sales@molnova.cn

